Christèle Desbois‐Mouthon

Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis†

Eduardo Schiffer, Chantal Housset, Wulfran Cacheux et al. · Hepatology · 2005 · 336 citations · Full text

Medicine, Oncology, Pharmacology +17

Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation

Christèle Desbois‐Mouthon, Axelle Cadoret, Marie-José Blivet-Van Eggelpoël et al. · Oncogene · 2001 · 321 citations

Life Sciences, Cell Biology, Molecular Biology +13

Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma

Victoria Tovar, Helena Cornellà, Agrin Moeini et al. · Gut · 2015 · 208 citations · Full text

Medicine, Oncology, Pharmacology +17

Implication of Metastasis Suppressor <i>NM23-H1</i> in Maintaining Adherens Junctions and Limiting the Invasive Potential of Human Cancer Cells

Mathieu Boissan, Olivier De Wever, Floria Lizárraga et al. · Cancer Research · 2010 · 184 citations · Full text

Medicine, Cell Biology, Oncology +17

Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells

Marie-José Blivet-Van Eggelpoël, Hamza Chettouh, Lynda Aoudjehane et al. · Journal of Hepatology · 2012 · 177 citations

Medicine, Cell Biology, Oncology +16